Even criteria that incorporate biological markers as a proxy for tumor behavior (e.g., alpha-fetoprotein, AFP, or des-gamma carboxyprothrombin, DCP, also known as protein-induced by vitamin K absence/antagonist-II, PIVKA-II) have limited sensitivity and specificity. The gene discussed is ACE; the disease is neoplasm.